|Lipomatous apocrine adenoma with syringocystadenoma papilliferum arising from the external auditory canal.|
|Jump to Full Text|
|PMID: 21854651 Owner: NLM Status: MEDLINE|
|A case of lipomatous tubular adenoma (LTA) with syringocystadenom papilliferum (SCAP) arising from the external auditory canal in a 25-year-old man is described and to the best of our knowledge through literature review, this kind of morphologic entity has not been reported before. Herein we reported the first case in the English literature in the world.|
|Tzu-Cheng Su; Ko-Hung Shen; Hsin-kai Wang; Pei-Yi Chu; Mei-Ling Chen|
|Type: Case Reports; Journal Article; Review Date: 2011-08-22|
|Title: Head & neck oncology Volume: 3 ISSN: 1758-3284 ISO Abbreviation: Head Neck Oncol Publication Date: 2011|
|Created Date: 2011-09-09 Completed Date: 2011-12-01 Revised Date: 2013-06-27|
Medline Journal Info:
|Nlm Unique ID: 101479704 Medline TA: Head Neck Oncol Country: England|
|Languages: eng Pagination: 36 Citation Subset: IM|
|Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan.|
|APA/MLA Format Download EndNote Download BibTex|
Cystadenocarcinoma / pathology*, surgery
Ear Canal / pathology*
Sweat Gland Neoplasms / pathology*
Syringoma / pathology*, surgery
Journal ID (nlm-ta): Head Neck Oncol
Publisher: BioMed Central
Copyright ©2011 Su et al; licensee BioMed Central Ltd.
Received Day: 6 Month: 7 Year: 2011
Accepted Day: 22 Month: 8 Year: 2011
collection publication date: Year: 2011
Electronic publication date: Day: 22 Month: 8 Year: 2011
Volume: 3First Page: 36 Last Page: 36
Publisher Id: 1758-3284-3-36
PubMed Id: 21854651
|Lipomatous apocrine adenoma with syringocystadenoma papilliferum arising from the external auditory canal|
|Tzu-Cheng Su1||Email: firstname.lastname@example.org|
|Ko-Hung Shen1||Email: email@example.com|
|Hsin-kai Wang2||Email: firstname.lastname@example.org|
|Pei-Yi Chu1||Email: email@example.com|
|Mei-Ling Chen1||Email: firstname.lastname@example.org|
1Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan
2Jen-Teh Junior College of Medicine, Nursing and Management, Department of Medical Technology, Miaoli, Taiwan
Tumors arising from the external ear canal are extremely rare. Exostosis and squamous cell carcinomas are the most commonly-encountered benign and malignant tumors, respectively. Tubular adenoma (TA), also named as tubular apocrine adenoma, tubular syringoadenoma, or tubulopapillary hidradenoma [1,2], was first reported as a new entity by Landry and Winkelmann in 1972 . Since then, less than one hundred cases of tubular adenoma were reported in the English literature . This type of rare tumors was reported at the scalp, extremity, and eyelid . Tubular adenoma originated in the external auditory canal was first reported by Lee and his colleague in 2005 . In Lee's report, he described a tubular apocrine adenoma with syringocystadenoma papilliferum. Here we described the first case of a lipomatous tubular adenoma with syringocystadenoma papilliferum arising from the external auditory canal.
A 25-year-old male was referred for hearing impairment and discharge on and off from left ear for a period of time. Family history is unremarkable and laboratory data is with normal limit. Pure tone audiometry evaluation was arranged and conductive hearing loss of left ear was identified. A mass noted in the left external auditory canal. High resolution computed tomography showed an approximately 0.8 × 0.6 cm soft tissue mass occupying within the left external ear canal near the opnening, without eroding canal wall. Tumor excision was performed and the resected tumor was submitted for pathological examination. The patient recovered uneventfully without evidence of recurrence nine months after operation.
Section of the tumor shows circumscribed lobules of well-differentiated double-layered tubular structures located in the deep dermis (Figure 1). The stroma is composed of fibrous tissue with intervening abundant adipocytes (Figure 2). The inner layers of cylindrical cells of the tubules have apocrine features showing "decapitation" secretion (positive for cytokeratin-7 and GCDFP-15) (Figure 3A and 3B). The tubules are surrounded by the outer layers of cuboidal or flattened cells with myoepithelial differentiation (positive for P63 and S-100) (Figure 3C and 3D). Abnomal mitotic figure, invasive border, and cellular atypia are not noted. No inflammatory cells are noted in the tumor. Lipomatous tubular adenoma is diagnosed. Section of the upper part of the tumor shows features of syringocystadenoma papilliferum with irregular papillary projections protruding into the invaginations of the surface epithelium. Transition from squamous epithelium to double-layered cuboidal and columnar epithelium is seen. Plasma cells admixed with lymphocytes is noted in the stroma. No nevus sebaceous is seen in the background of the tumor.
TA is a rare entity and sometimes occurs with SCAP. SCAP was previously reported to be often associated with pre-existing nevus sebaceous , and morphologic features of nevus sebaceous seldom existed in SCAP with TA . No nevus sebaceous is seen in our case. Controversy about the relationship of TA and SCAP still exists. TA was considered as a minor variant of SCAP by some scholars , but others have suggested that TA is a distinct clinical entity . In Kazakov's recently published study, 67 cases of TA, SCAP, and their lookalikes were assessed by four dermatopathologists. Only 29 cases got concurrent agreement and interobserver variation existed in other 38 cases.
TA or SCAP was reported to have certain relationship with human papillomavirus infection  and a human papillomavirus induced non-neoplastic process leading to TA or SCAP was also speculated by some authors . Warty surface or koilocytotic feature is not seen in our case.
Immunohistochemical study may be useful in puzzling cases. S-100 protein was reported to be detected in the peripheral myoepithelial cells in the TA and failed to be present in the SCAP [7,10], which was consistent with the immunohistochemical results of our presented case.
Treatment of LTA with SCAP includes careful preoperative evaluation and surgical resection with safe margin. Computed tomography is useful in evaluating the tumor and surrounding tissue.
Our case shows the characteristic SCAP and TA with abundant adipocytes in the upper and the deeper portion, respectively. In a thorough research for PUBMED, this is the first reported case with LTA and SCAP occurring in the external auditory canal. Although Lee at al  published the first case of TA occurring in the external auditory canal, but abundant adipocytes are mixed with fibrous tissue in the stroma of TA in our case, and this kind of morphologic presentation has not yet reported in the external auditory canal.
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal
LTA: Lipomatous tubular adenoma; SCAP: syringocystadenom papilliferum; TA: tubular adenoma.
The authors declare that they have no competing interests.
TS: wrote, aligned and drafted the manuscript. KS participated in the collection of the data, literature review. HW: collected clinical and pathological records. PC: took the pictures for this manuscript. MC: modified this manuscript and make and final approval.
All authors read and approved the final manuscript.
|Kazakov DV,Bisceglia M,Calonje E,Tubular adenoma and syringocystadenoma papilliferum: a reappraisal of their relationship. An interobserver study of a series, by a panel of dermatopathologistsAm J DermatopatholYear: 2007292566310.1097/DAD.0b013e3180576fd917519623|
|LeBoit PE,Burg G,Weedon D,World Health Organization Classification of Tumours. Pathology and Genetics of Skin TumoursYear: 2006Lyon, France: IARC Press|
|Landry M,Winkelmann RK,An unusual tubular aprocrine adenomaArch DermatolYear: 19721058697910.1001/archderm.105.6.8694113017|
|Requena L,Kiryu H,Ackerman AB,Neoplasms with Apocrine DifferentiationYear: 1998Philadelphia, Pa: Lippincott-Raven|
|Stokes J,Ironside J,Smith C,Dhillon B,Tubular apocrine adenoma- an unusual eyelid tumorEyeYear: 200519237910.1038/sj.eye.670142615105822|
|Lee CK,Jang KT,Cho YS,Tubular apocrine adenoma with syringocystadenoma papilliferum arising from the external auditory canalJ Laryngol OtolYear: 20051191004616354370|
|Ishiko A,Shimizu H,Inamoto N,Nakmura K,Is tubular apocrine adenoma a distinct clinical entity?Am J DermatopatholYear: 199315482710.1097/00000372-199310000-000148238787|
|Fisher TL,Tubular apocrine adenoma (Letter to editor)Arch DermatolYear: 19731071374345346|
|Hsu PJ,Liu CH,Huang CJ,Mixed tubulopapillary hidradenoma and syringocystadenoma papilliferum occurring as a verrucous tumorJ Cutan PatholYear: 2003302061010.1034/j.1600-0560.2003.00031.x12641782|
|Aktepe F,Demir Y,Dilek FH,Tubular apocrine adenoma in association with syringocystadenoma papilliferumDermatol Online JYear: 20039712639465|
Keywords: tubular adenoma, syringocystadenoma papilliferum, external auditory canal.
Previous Document: Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid f...
Next Document: Haplo2Ped: a tool using haplotypes as markers for linkage analysis.